Cardiol Therapeutics Inc (CRDL)
2.35
+0.12
(+5.38%)
USD |
NASDAQ |
May 24, 16:00
2.34
-0.01
(-0.43%)
After-Hours: 20:00
Cardiol Therapeutics Shareholders Equity (Quarterly): 14.85M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 14.85M |
December 31, 2023 | 21.29M |
September 30, 2023 | 25.65M |
June 30, 2023 | 29.24M |
March 31, 2023 | 33.68M |
December 31, 2022 | 38.46M |
September 30, 2022 | 42.91M |
June 30, 2022 | 48.78M |
March 31, 2022 | 55.44M |
December 31, 2021 | 59.79M |
September 30, 2021 | 22.80M |
June 30, 2021 | 27.21M |
Date | Value |
---|---|
March 31, 2021 | 14.45M |
December 31, 2020 | 10.41M |
September 30, 2020 | 16.79M |
June 30, 2020 | 19.11M |
March 31, 2020 | 8.832M |
December 31, 2019 | 11.23M |
September 30, 2019 | 12.57M |
June 30, 2019 | 14.92M |
March 31, 2019 | 16.43M |
December 31, 2018 | 16.35M |
September 30, 2018 | -2.484M |
December 31, 2017 | 2.270M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.832M
Minimum
Mar 2020
59.79M
Maximum
Dec 2021
26.42M
Average
22.05M
Median
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 23.04M |
Total Liabilities (Quarterly) | 8.191M |